Literature DB >> 3581639

Hazards of splenic embolization.

L M Back, C E Bagwell, B H Greenbaum, M B Marchildon.   

Abstract

Perceived high operative risk for splenectomy in children with hematologic disorders and hypersplenism has led to attempts at transcatheter splenic embolization (TSE) as a possibly safer alternative. A recent experience with a child who presented with an apparent acute subcapsular hematoma after TSE and who underwent complicated emergency splenectomy prompted review of the risks and complications of TSE. Although theoretically attractive in many respects, TSE is associated with significant morbidity. The resultant diagnostic and therapeutic difficulties of this procedure can potentially complicate patient management, and the often life-threatening sequelae warrant considerable restraint in its use. In addition, TSE often fails to produce the desired, long-term hematologic response. Because of the morbidity and risk associated with TSE, primary operative intervention is advised for most children in whom splenectomy is indicated. Morbidity associated with the direct operative approach may be minimized by judicious use of blood components and by meticulous surgical technique.

Entities:  

Mesh:

Year:  1987        PMID: 3581639     DOI: 10.1177/000992288702600605

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  3 in total

1.  Radiofrequency ablation for hypersplenism in patients with liver cirrhosis: a pilot study.

Authors:  Quanda Liu; Kuansheng Ma; Zhenping He; Jiahong Dong; Xin Hua; Xuequan Huang; Liang Qiao
Journal:  J Gastrointest Surg       Date:  2005 May-Jun       Impact factor: 3.452

2.  Splenic artery embolization as an adjunctive procedure for portal hypertension.

Authors:  Mitchell Smith; Charles E Ray
Journal:  Semin Intervent Radiol       Date:  2012-06       Impact factor: 1.513

3.  Left-sided portal hypertension caused by idiopathic splenic vein stenosis improved by splenectomy: a case report.

Authors:  Hikaru Hayashi; Akira Shimizu; Hiroaki Motoyama; Koji Kubota; Tsuyoshi Notake; Tomohiko Ikehara; Koya Yasukawa; Akira Kobayashi; Yuji Soejima
Journal:  Surg Case Rep       Date:  2020-06-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.